Items where authors include "Cosman, F."

Article

Miller, P.D., Bilezikian, J.P., Fitzpatrick, L.A. et al. (4 more authors) (2020) Abaloparatide: an anabolic treatment to reduce fracture risk in postmenopausal women with osteoporosis. Current Medical Research and Opinion, 36 (11). pp. 1861-1872. ISSN 0300-7995

Kim, T.Y., Bauer, D.C., McNabb, B.L. et al. (4 more authors) (2019) Comparison of BMD changes and bone formation marker levels 3 years after bisphosphonate discontinuation: FLEX and HORIZON-PFT Extension I trials. Journal of Bone and Mineral Research, 34 (5). pp. 810-816. ISSN 0884-0431

Cummings, S.R., Cosman, F., Lewiecki, E.M. et al. (17 more authors) (2017) Goal-Directed Treatment for Osteoporosis: A Progress Report from the ASBMR-NOF Working Group on Goal-Directed Treatment for Osteoporosis. Journal of Bone and Mineral Research, 32 (1). pp. 3-10. ISSN 0884-0431

Jacques, R.M., Boonen, S., Cosman, F. et al. (4 more authors) (2012) Relationship of changes in total hip bone mineral density to vertebral and nonvertebral fracture risk in women with postmenopausal osteoporosis treated with once-yearly zoledronic acid 5 mg: The HORIZON-Pivotal Fracture Trial (PFT). Journal of Bone and Mineral Research, 27 (8). 1627 - 1634. ISSN 1523-4681

Boonen, S., Eastell, R. orcid.org/0000-0002-0323-3366, Su, G. et al. (8 more authors) (2012) Time to onset of antifracture efficacy and year-by-year persistence of effect of zoledronic acid in women with osteoporosis. Journal of Bone and Mineral Research , 27 (7). pp. 1487-1493. ISSN 0884-0431